Ak. Andreassen et al., HYPERTENSION PROPHYLAXIS WITH OMEGA-3-FATTY-ACIDS IN HEART-TRANSPLANTRECIPIENTS, Journal of the American College of Cardiology, 29(6), 1997, pp. 1324-1331
Objectives. This study sought to determine whether omega-3 fatty acids
act as hypertension prophylaxis in heart transplant recipients and ha
ve an impact on vascular reactivity. Background. Cyclosporine-induced
hypertension is probably related to endothelial dysfunction. Suggested
vasodilatory mechanisms of omega-3 fatty acids may therefore be parti
cularly beneficial in heart transplant recipients. Methods. Heart tran
splant recipients were randomized to receive either 4 g of omega-3 fat
ty acids (treatment group, n = 14) daily or corn oil (placebo group, n
= 14) from the fourth postoperative day. Twenty-four hour blood press
ure monitoring was performed at day 12 and 1, 2, 3 and 6 months postop
eratively. Microvascular endothelium-dependent vasodilation, evaluated
by skin laser Doppler perfusion measurements of postocclusive reactiv
e hyperemia, was determined preoperatively and at the end of the study
. Results. With comparable characteristics at the time of randomizatio
n, blood levels of cyclosporine did not at any point differ between th
e groups. After 6 months, systolic blood pressure decreased 2 +/- 4 mm
Hg (mean a SEM) in the treatment group and increased 17 +/- 4 mm Hg i
n the placebo group (p < 0.01), whereas diastolic blood pressure incre
ased 10 +/- 3 and 21 +/- 2 mm Hg (p < 0.01), respectively. The decreas
e in systolic blood pressure was inversely proportional to increases i
n concentrations of serum eicosapentaenoic and docosahexaenoic acid (p
= 0.01). After 6 months, five patients in the treatment group and nin
e in the placebo group needed additional antihypertensive treatment. A
lthough the endothelial-dependent phase of the reactive hyperemic resp
onse remained unchanged in the treatment group, it decreased significa
ntly in the placebo group. Conclusions. Postoperative daily administra
tion of 4 g of omega-3 fatty acids in heart transplant recipients is e
ffective as hypertension prophylaxis, depending on increases in serum
eicosapentaenoic and docosahexaenoic acids. Preservation of microvascu
lar endothelial function, demonstrated by a more pronounced response t
o forearm skin ischemia in the treatment group, may contribute to the
hypotensive role of omega-3 fatty acids. (C) 1997 by the American Coll
ege of Cardiology.